Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Potential Rise

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Feb 06, 2023 12:43pm

239 Views

Post# 35269532

RE:Potential Rise

EnriqueSuave ... You think that adding up to 9 new sites would be to validate a cohort of patients receiving let's say 4 doses, instead of just the actual 2 ones? If so, that would be interesting and could only come on a FDA guidance/suggestion. If so, that would be excellent.

I'd be very interesting to first see the efficacy %s of the optimized group (p#13-25) as my numbers already stand above 65% for their 90-days CR and 450-days DR.

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record